Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
Various angiotensins, bradykinins, and related peptides were examined for their inhibitory activity against several enkephalin-degrading enzymes, including an aminopeptidase and a dipeptidyl aminopeptidase, purified from a membrane-bound fraction of monkey brain, and an endopeptidase, purified from the rabbit kidney membrane fraction. Angiotensin derivatives having a basic or neutral amino acid at the N-terminus showed strong inhibition of the aminopeptidase. Dipeptidyl aminopeptidase was inhibited by angiotensins II and III and their derivatives, whereas the endopeptidase was inhibited by angiotensin I and its derivatives. The most potent inhibitor of aminopeptidase and dipeptidyl aminopeptidase was angiotensin III, which completely inhibited the degradation of enkephalin by enzymes in monkey brain or human CSF. The Ki values for angiotensin III against aminopeptidase, dipeptidyl aminopeptidase, endopeptidase, and angiotensin-converting enzyme, which degraded enkephalin, were 0.66 X 10(-6), 1.03 X 10(-6), 2.3 X 10(-4), and 1.65 X 10(-6) M, respectively. Angiotensin III potentiated the analgesic activity of Met-enkephalin after intracerebroventricular coadministration to mice in the hot plate test. Angiotensin III itself also displayed analgesic activity in that test. These actions were blocked by the specific opiate antagonist naloxone.
D000110:Acetylcholinesterase / Q000378:metabolism; D000626:Aminopeptidases / Q000037:antagonists & inhibitors*; D000700:Analgesics; D000804:Angiotensin II / Q000031:analogs & derivatives*; D000805:Angiotensin III / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / Q000037:antagonists & inhibitors*; D010450:Endopeptidases; D004745:Enkephalins / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology; D051379:Mice; D008813:Mice, Inbred ICR; D009270:Naloxone / Q000494:pharmacology; D015260:Neprilysin; D011480:Protease Inhibitors
D000700:Analgesics; D000806:Angiotensin-Converting Enzyme Inhibitors; D002800:Cholinesterase Inhibitors; D004745:Enkephalins; D011480:Protease Inhibitors; D000804:Angiotensin II; D000805:Angiotensin III; D009270:Naloxone; D000110:Acetylcholinesterase; D010450:Endopeptidases; D000626:Aminopeptidases; C025579:enkephalin degrading enzyme; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D015260:Neprilysin